Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, April 20, 2015

Bionomics Initiates Phase II Clinical Trial of BNC210 for Treatment of Anxiety

The study will use functional magnetic resonance imaging to assess the effects of BNC210 on brain activity in patients suffering from anxiety. "BNC210 has the potential to significantly improve the lives of anxiety sufferers, and we believe that with effective management of anxiety there is the potential to reduce the huge impact of the disease on societal and healthcare resources," said Dr. "Currently, there is a large unmet medical need for fast-acting anxiolytic agents that lack the side effects observed with existing treatments, which include sedation and addiction, as well as negative side effects on memory and body movement.
http://ift.tt/1EjbAxb

No comments:

Post a Comment

Popular Stem Cell Roundup Posts